A Phase III Double-blind, Randomized, Parallel Group, Multicenter Placebo-controlled Trial to Study the Efficacy and Safety of Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007725/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study was a Phase III, double-blind, placebo-controlled, randomized study to evaluate the
efficacy of caplacizumab in more rapidly restoring normal platelet counts as measure of
prevention of further microvascular thrombosis
提供机构：
Vivli
创建时间：
2022-02-10
